NUK - logo

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov NUK. Za polni dostop se PRIJAVITE.

1
zadetkov: 5
1.
  • Substitution mutational sig... Substitution mutational signatures in whole-genome-sequenced cancers in the UK population
    Degasperi, Andrea; Zou, Xueqing; Amarante, Tauanne Dias ... Science (American Association for the Advancement of Science), 04/2022, Letnik: 376, Številka: 6591
    Journal Article
    Recenzirano
    Odprti dostop

    Whole-genome sequencing (WGS) permits comprehensive cancer genome analyses, revealing mutational signatures, imprints of DNA damage and repair processes that have arisen in each patient's cancer. We ...
Celotno besedilo
2.
  • Insights from multi-omic mo... Insights from multi-omic modeling of neurodegeneration in xeroderma pigmentosum using an induced pluripotent stem cell system
    Badja, Cherif; Momen, Sophie; Koh, Gene Ching Chiek ... Cell reports (Cambridge), 06/2024, Letnik: 43, Številka: 6
    Journal Article
    Recenzirano
    Odprti dostop

    Xeroderma pigmentosum (XP) is caused by defective nucleotide excision repair of DNA damage. This results in hypersensitivity to ultraviolet light and increased skin cancer risk, as sunlight-induced ...
Celotno besedilo
3.
  • All Driven by Energy Demand... All Driven by Energy Demand? Integrative Comparison of Metabolism of Enterococcus faecalis Wildtype and a Glutamine Synthase Mutant
    Loghmani, Seyed Babak; Zitzow, Eric; Koh, Gene Ching Chiek ... Microbiology spectrum, 2022-Apr-27, Letnik: 10, Številka: 2
    Journal Article
    Recenzirano
    Odprti dostop

    Lactic acid bacteria (LAB) play a significant role in biotechnology, e.g., food industry and also in human health. Many LAB genera have developed a multidrug resistance in the past few years, causing ...
Celotno besedilo

PDF
4.
  • The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells
    Koh, Gene Ching Chiek; Boushaki, Soraya; Zhao, Salome Jingchen ... Nature genetics, 01/2024, Letnik: 56, Številka: 1
    Journal Article
    Recenzirano
    Odprti dostop

    The chemotherapeutic agent CX-5461, or pidnarulex, has been fast-tracked by the United States Food and Drug Administration for early-stage clinical studies of BRCA1-, BRCA2- and PALB2-mutated ...
Celotno besedilo
5.
Celotno besedilo

PDF

Nalaganje filtrov